SJ

Sakshi Juneja

Active Director Director DIN 09723511
DIN 09723511 First appointment Sep 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value •••• Premium profile

About Sakshi Juneja

Data last updated:

Sakshi Juneja is a Director at Ria Biosciences Private Limited (since 2022). The company operates in Chemicals. Ria Biosciences Private Limited reported revenue of ₹8.34 Cr (FY 2025).

DIN 09723511
Primary Designation Director
Industry Chemicals
First Appointment 01 Sep 2022
Oldest Company Age 4 yrs
Largest company Ria Biosciences Private Limited · ₹8.34 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ria Biosciences Private Limited U24309DL2022PTC404014
Director01 Sep 20222022₹8.34 Cr (FY 2025)Active

Board colleagues of Sakshi Juneja

NameDINCompanyDesignation
Rakesh Bansal05159473Ria Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ria Biosciences Private Limited
Premium access

Shareholding and investment profile for Sakshi Juneja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sakshi Juneja

Sakshi Juneja currently holds 1 directorship: Ria Biosciences Private Limited (Director, since 01 Sep 2022, revenue ₹8.34 Cr (FY 2025)).

Sakshi Juneja was first appointed on 01 Sep 2022 as Director at Ria Biosciences Private Limited.

The current boards of Sakshi Juneja's companies include Rakesh Bansal (Ria Biosciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available